TG Therapeutics (TGTX) Q4 2025 Earnings Transcript
Source: Motley Fool
2026-02-26 14:11:29 ET
Image source: The Motley Fool.
Thursday, Feb. 26, 2026 at 8:30 a.m. ET
Need a quote from a Motley Fool analyst? Email pr@fool.com
TG Therapeutics Inc.
NASDAQ: TGTX
TGTX Trading
-1.72% G/L:
$28.30 Last:
464,104 Volume:
$28.50 Open:
TGTX Latest News
March 06, 2026 07:30:00 am
TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the American Academy of Neurology 2026 Annual Meeting
February 26, 2026 07:00:00 am
TG Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Raises BRIUMVI Revenue Guidance
TGTX Stock Data
$4,661,971,279
141,867,445
0.11%
146
N/A
Biotechnology & Life Sciences
Healthcare
US
Morrisville
